Dr. David Gary Lott, MD

Dr. Lott practices at Mayo Clinic Ambulatory Surgery Center - Scottsdale in Scottsdale, Arizona.

Dr. Lott's NPI, 1154506913, was assigned on December 29, 2007. Dr. Lott graduated from Carver College of Medicine in 2004. Dr. Lott holds Arizona license 44899.

Dr. Lott's primary practice is Mayo Clinic Ambulatory Surgery Center - Scottsdale, at 13400 East Shea Boulevard, Scottsdale, AZ 85259. The practice phone is (480) 342-4201.

Dr. Lott's primary practice is Mayo Clinic Ambulatory Surgery Center - Scottsdale in Scottsdale, Arizona. Dr. Lott is also affiliated with Mayo Clinic Hospital - Phoenix. The medical group on file is Mayo Clinic Arizona. Dr. Lott's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lott practices, 2 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Lott's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Lott is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Lott's licenses on file in 3 states: Arizona, Massachusetts and Ohio.

Dmand AI lists larynx and vocal cord disease among the conditions Dr. Lott treats.

CMS data shows 463 Medicare services from Dr. Lott across 9 procedure codes in 2024, for 174 Medicare patients. Medicare paid $40,902 for them.

CMS counts 174 Medicare patients who saw Dr. Lott in 2024. The largest group is 65 to 74, with 78 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lott's median patient age at 70, with 48% women.

In 2024, Dr. Lott wrote 23 Medicare Part D claims for 14 patients. 83% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $28 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Lott for performance year 2024, reported as part of a group. Dr. Lott accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lott as offering telehealth. CMS counts 16 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Lott, more than 47% of the clinicians it reports for that procedure.

Spinal fusion: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 74 papers to Dr. Lott, published from 2009 to 2025. 2020 was the busiest year, with 9. The most frequent topics are Larynx, Laryngeal Neoplasms and Laryngoscopy. Dr. Lott has published most often in Laryngoscope. Dr. Lott's most frequent co-authors are Michael L. Hinni, MD, Yassmeen Abdel-Aty, MD and Charles H. Adler, MD.

Dmand AI links Dr. Lott to 4 clinical trials. Conditions studied include Diverticulum, Esophageal, Idiopathic subglottic tracheal stenosis and Recurrent respiratory papillomatosis. Mayo Clinic sponsors the most, 2.

CMS Open Payments shows 35 general payments to Dr. Lott from 10 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 44% of the total. Merz North America, Inc. paid the most, $6,000.

Dr. Lott graduated from Carver College of Medicine in 2004.

Dr. Lott is in network with 8 carriers, including Excellus BlueCross BlueShield, United Healthcare and Aetna. PPO plans come from the most carriers, 4. Check the plan with the practice before a visit.